News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
72,070 Results
Type
Article (1929)
Company Profile (2)
Press Release (70139)
Section
Business (21474)
Career Advice (9)
Deals (4555)
Drug Development (8161)
FDA (1804)
Job Trends (800)
News (37032)
Policy (3561)
Tag
Academia (95)
Accelerated approval (2)
Allergies (15)
Alliances (8174)
ALS (12)
Alzheimer's disease (156)
Antibody-drug conjugate (ADC) (63)
Approvals (1913)
Artificial intelligence (25)
Autoimmune disease (11)
Automation (1)
Bankruptcy (8)
Best Places to Work (585)
Biosimilars (63)
Biotechnology (5)
Bladder cancer (26)
Brain cancer (5)
Breast cancer (52)
Cancer (485)
Cardiovascular disease (16)
Career advice (9)
CAR-T (12)
Cell therapy (47)
Cervical cancer (3)
Clinical research (7430)
Collaboration (244)
Compensation (17)
Complete response letters (5)
COVID-19 (194)
C-suite (63)
Cystic fibrosis (6)
Data (579)
Depression (11)
Diabetes (30)
Diagnostics (621)
Digital health (4)
Drug discovery (33)
Drug pricing (1)
Duchenne muscular dystrophy (29)
Earnings (7932)
Events (7349)
Executive appointments (60)
FDA (2187)
Fibrodysplasia Ossificans Progressiva (1)
Funding (118)
Gene editing (5)
Generative AI (1)
Gene therapy (29)
GLP-1 (64)
Government (235)
Grass and pollen (1)
Guidances (38)
Healthcare (1079)
HIV (1)
Huntington's disease (2)
IgA nephropathy (18)
Immunology and inflammation (5)
Immuno-oncology (4)
Indications (12)
Infectious disease (208)
Inflammatory bowel disease (23)
Inflation Reduction Act (1)
Influenza (11)
Intellectual property (32)
IPO (1638)
Job creations (241)
Job search strategy (9)
JPM (3)
Layoffs (6)
Legal (953)
Liver cancer (18)
Lung cancer (90)
Lymphoma (36)
Manufacturing (84)
MASH (12)
Medical device (1157)
Medtech (1164)
Mergers & acquisitions (3078)
Metabolic disorders (72)
Multiple sclerosis (16)
NASH (1)
Neurodegenerative disease (25)
Neuropsychiatric disorders (5)
Neuroscience (265)
NextGen: Class of 2026 (219)
Non-profit (63)
Obesity (25)
Opinion (1)
Ovarian cancer (21)
Pain (11)
Pancreatic cancer (15)
Parkinson's disease (32)
Partnered (3)
Patents (50)
Patient recruitment (47)
Peanut (1)
People (5095)
Pharmaceutical (2)
Pharmacy benefit managers (4)
Phase 1 (2007)
Phase 2 (3130)
Phase 3 (2816)
Pipeline (568)
Policy (1)
Postmarket research (241)
Preclinical (692)
Press Release (2)
Prostate cancer (20)
Radiopharmaceuticals (22)
Rare diseases (60)
Real estate (606)
Regulatory (2868)
Reports (6)
Research institute (97)
RNA editing (2)
RSV (2)
Schizophrenia (16)
Series A (23)
Series B (21)
Service/supplier (1)
Sickle cell disease (6)
Spinal muscular atrophy (5)
Sponsored (1)
Startups (424)
Stomach cancer (1)
Supply chain (12)
Vaccines (39)
Venture capital (5)
Weight loss (5)
Women's health (4)
Date
Last 7 days (50)
Last 30 days (212)
Last 365 days (2728)
2026 (288)
2025 (2684)
2024 (3253)
2023 (3814)
2022 (7016)
2021 (6374)
2020 (5877)
2019 (3867)
2018 (3010)
2017 (3560)
2016 (3172)
2015 (4030)
2014 (3020)
2013 (2600)
2012 (2775)
2011 (2902)
2010 (2663)
Location
Africa (88)
Alabama (3)
Arizona (11)
Asia (21975)
Australia (2462)
California (636)
Canada (372)
China (366)
Colorado (5)
Connecticut (21)
Delaware (6)
Europe (13059)
Florida (60)
Georgia (13)
Illinois (30)
India (34)
Indiana (13)
Japan (240)
Kansas (5)
Louisiana (1)
Maine (4)
Maryland (103)
Massachusetts (482)
Michigan (7)
Minnesota (34)
Missouri (3)
Nebraska (2)
Nevada (9)
New Hampshire (1)
New Jersey (378)
New York (225)
North Carolina (90)
Northern California (270)
Ohio (3)
Oregon (1)
Pennsylvania (106)
Rhode Island (1)
South America (108)
Southern California (298)
Tennessee (1)
Texas (52)
United States (2379)
Utah (24)
Virginia (44)
Washington D.C. (3)
Washington State (47)
Wisconsin (7)
72,070 Results for "phoremost ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
PhoreMost Introduces GlueSEEKER Platform for Discovery of Molecular Glue Degraders
PhoreMost Ltd., a leading UK biopharmaceutical company unlocking the next generation of drug targets, announced the introduction of GlueSEEKER™.
May 21, 2024
·
2 min read
Business
PhoreMost Achieves Second Milestone in Target Discovery Alliance with Boehringer Ingelheim
PhoreMost Ltd., has triggered a second milestone payment in its multi-project target discovery collaboration with Boehringer Ingelheim.
June 3, 2024
·
2 min read
Press Releases
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency
January 19, 2026
·
4 min read
Press Releases
QureBio Ltd. to Present at ASCO 2026 its Q-1802 Phase II Clinical Results
January 29, 2026
·
3 min read
Press Releases
Faron Pharmaceuticals Ltd: Appointment of CFO
December 1, 2025
·
3 min read
Press Releases
vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737
February 2, 2026
·
7 min read
Press Releases
Ayrmid Pharma Ltd Announces Additional Positive Results for Omisirge(R) in Treating Severe Aplastic Anemia (SAA) Presented at TANDEM
February 5, 2026
·
4 min read
Press Releases
Faron Pharmaceuticals Ltd: Holding(s) in Company
December 5, 2025
·
3 min read
Press Releases
Tenpoint Therapeutics Ltd. Announces FDA Approval of YUVEZZI™, the First and Only Combination Eye Drop Approved to Treat Presbyopia
January 29, 2026
·
8 min read
Press Releases
Medicus Pharma Ltd. Announces Amendment to LifeArc License Improving Teverelix® Long-Term Economic and Development Profile
January 22, 2026
·
13 min read
1 of 7,207
Next
